These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9753023)

  • 1. Myocardial fibrin deposits in the first month after transplantation predict subsequent coronary artery disease and graft failure in cardiac allograft recipients.
    Labarrere CA; Nelson DR; Faulk WP
    Am J Med; 1998 Sep; 105(3):207-13. PubMed ID: 9753023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial activation and development of coronary artery disease in transplanted human hearts.
    Labarrere CA; Nelson DR; Faulk WP
    JAMA; 1997 Oct; 278(14):1169-75. PubMed ID: 9326477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum cardiac troponin-T concentrations predict development of coronary artery disease in heart transplant patients.
    Faulk WP; Labarrere CA; Torry RJ; Nelson DR
    Transplantation; 1998 Nov; 66(10):1335-9. PubMed ID: 9846519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac-specific troponin I levels and risk of coronary artery disease and graft failure following heart transplantation.
    Labarrere CA; Nelson DR; Cox CJ; Pitts D; Kirlin P; Halbrook H
    JAMA; 2000 Jul; 284(4):457-64. PubMed ID: 10904509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular antithrombin and clinical outcome in heart transplant patients.
    Labarrere CA; Torry RJ; Nelson DR; Miller SJ; Pitts DE; Kirlin PC; Halbrook HG
    Am J Cardiol; 2001 Feb; 87(4):425-31. PubMed ID: 11179526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular tissue plasminogen activator and the development of coronary artery disease in heart-transplant recipients.
    Labarrere CA; Pitts D; Nelson DR; Faulk WP
    N Engl J Med; 1995 Oct; 333(17):1111-6. PubMed ID: 7565949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical model to predict risk for coronary artery disease and failure in heart transplant patients.
    Labarre CA; Nelson DR; Pitts DE; Kirlin PC; Halbrook H
    Am J Transplant; 2001 Sep; 1(3):251-9. PubMed ID: 12102259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue plasminogen activator, plasminogen activator inhibitor-1, and fibrin as indexes of clinical course in cardiac allograft recipients. An immunocytochemical study.
    Labarrere CA; Pitts D; Halbrook H; Faulk WP
    Circulation; 1994 Apr; 89(4):1599-608. PubMed ID: 8149527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies to endothelial cells identify myocardial damage and predict development of coronary artery disease in patients with transplanted hearts.
    Faulk WP; Rose M; Meroni PL; Del Papa N; Torry RJ; Labarrere CA; Busing K; Crisp SJ; Dunn MJ; Nelson DR
    Hum Immunol; 1999 Sep; 60(9):826-32. PubMed ID: 10527389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of serum-soluble intercellular adhesion molecule-1 for the noninvasive risk assessment of transplant coronary artery disease, posttransplant ischemic events, and cardiac graft failure.
    Labarrere CA; Nelson DR; Miller SJ; Nieto JM; Conner JA; Pitts DE; Kirlin PC; Halbrook HG
    Circulation; 2000 Sep; 102(13):1549-55. PubMed ID: 11004146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytomegalovirus infection and accelerated cardiac allograft vasculopathy in human cardiac allografts.
    Koskinen PK; Nieminen MS; Krogerus LA; Lemström KB; Mattila SP; Häyry PJ; Lautenschlager IT
    J Heart Lung Transplant; 1993; 12(5):724-9. PubMed ID: 8241209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring of allograft vasculopathy by intravascular ultrasound one month and one year after heart transplantation: A single center study.
    Bedanova H; Orban M; Tretina M; Fila P; Horvath V; Krejci J; Nemec P
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Mar; 160(1):130-5. PubMed ID: 26220510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular abnormalities and cardiomyocyte lipofuscin deposits in endomyocardial biopsy specimens of heart transplant recipients: are they related to the development of cardiac allograft vasculopathy?
    Zakliczynski M; Nozynski J; Konecka-Mrowka D; Krynicka-Mazurek A; Swierad M; Maruszewski M; Przybylski R; Zembala M
    J Thorac Cardiovasc Surg; 2009 Jul; 138(1):215-21, 221.e1-3. PubMed ID: 19577082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue Doppler imaging detects severely abnormal myocardial velocities that identify children with pre-terminal cardiac graft failure after heart transplantation.
    Fyfe DA; Ketchum D; Lewis R; Sabatier J; Kanter K; Mahle W; Vincent R
    J Heart Lung Transplant; 2006 May; 25(5):510-7. PubMed ID: 16678028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of corticosteroid-free maintenance immunosuppression on allograft coronary artery disease after cardiac transplantation.
    Ratkovec RM; Wray RB; Renlund DG; O'Connell JB; Bristow MR; Gay WA; Karwande SV; Doty DB; Millar RC; Menlove RL
    J Thorac Cardiovasc Surg; 1990 Jul; 100(1):6-12. PubMed ID: 2366566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Capillary deposition of the complement fragment C4d in cardiac allograft biopsies is associated with allograft vasculopathy.
    Poelzl G; Ullrich R; Huber A; Ulmer H; Antretter H; Hoefer D; Mairinger T; Laufer G; Pachinger O; Schwarzacher S
    Transpl Int; 2005 Mar; 18(3):313-7. PubMed ID: 15730492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular brachytherapy for treatment of cardiac allograft vasculopathy.
    Klauss V; Stempfle H; Theisen K; Kantlehner R; Poellinger B; Reichart B; Schiele TM
    J Heart Lung Transplant; 2001 Jul; 20(7):792-4. PubMed ID: 11448814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiogenic shock and coronary endothelial dysfunction predict cardiac allograft vasculopathy after heart transplantation.
    Lopez-Fernandez S; Manito-Lorite N; Gómez-Hospital JA; Roca J; Fontanillas C; Melgares-Moreno R; Azpitarte-Almagro J; Cequier-Fillat A
    Clin Transplant; 2014 Dec; 28(12):1393-401. PubMed ID: 25284267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. European Association of Cardiovascular Imaging/Cardiovascular Imaging Department of the Brazilian Society of Cardiology recommendations for the use of cardiac imaging to assess and follow patients after heart transplantation.
    Badano LP; Miglioranza MH; Edvardsen T; Colafranceschi AS; Muraru D; Bacal F; Nieman K; Zoppellaro G; Marcondes Braga FG; Binder T; Habib G; Lancellotti P;
    Eur Heart J Cardiovasc Imaging; 2015 Sep; 16(9):919-48. PubMed ID: 26139361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes after percutaneous coronary artery revascularization procedures for cardiac allograft vasculopathy in pediatric heart transplant recipients: A multi-institutional study.
    Jeewa A; Chin C; Pahl E; Atz AM; Carboni MP; Pruitt E; Naftel DC; Rodriguez R; Dipchand AI;
    J Heart Lung Transplant; 2015 Sep; 34(9):1163-8. PubMed ID: 25578627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.